Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 307 clinical trials
None
Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer

The objective is to investigate the efficacy and safety of raltitrexed-based chemotherapy plus bevacizumab in the treatment of advanced colorectal cancer

  • 5 views
  • 05 Sep, 2021
  • 4 locations
None
Neoadjuvant IBI308 Bevacizumab Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC

The purpose of this study is to studying neoadjuvant IBI308, bevacizumab, plus pemetrexed and carboplatin followed by surgery to see how well it works in treating patients with unresectable

  • 0 views
  • 22 Jan, 2021
  • 1 location
None
The Effects of RFA in Combination With Second-line Chemotherapy and Bevacizumab on Unresectable CRLM

Basing on the strong evidence from former researches, patients with CRLM can benefit from the treatment of bevacizumab combined with sencond-line chemotherapy. Recently, although with the

  • 8 views
  • 22 Jan, 2021
None
FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRC

FOLFIRI in case of toxicity. Standard arm A: The patient will be treated with FOLFOXIRI plus bevacizumab for up to 12 cycles (24 weeks) or until progression (if the latter occurs before

bevacizumab
leucovorin
folfoxiri
BRAF
neutrophil count
  • 1 views
  • 23 Jan, 2021
  • 1 location
None
TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab

This is a phase II, open-Label clinical trial to evaluate the safety and efficacy of TTAC-0001 in patients with recurrent glioblastoma who was progressed on bevacizumab including therapy.

bevacizumab
glioblastoma multiforme
neutrophil count
aptt
measurable disease
  • 4 views
  • 26 Sep, 2021
  • 3 locations
None
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body

bevacizumab
cancer treatment
solid tumors
vitamin d
metastatic colorectal adenocarcinoma
  • 88 views
  • 19 Oct, 2021
  • 980 locations
None
Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma

The aim of this study is to make preliminary assessment of PD-L1 and other immune related biomarkers that might act as predictors of anti-tumor activity of Nivolumab in patients with recurrent glioblastoma

temozolomide
recurrent disease
bevacizumab
recurrent glioblastoma
platelet count
  • 0 views
  • 25 Jan, 2021
  • 1 location
None
Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose

injections, laser selective hmostatses , embolization or surgical dermoplasties ) allow for some short-term remissions . Bevacizumab is an antiangiogenic use in the treatment of colorectal cancers . It is

bevacizumab
epistaxis
remissions
blood transfusion
colorectal cancers
  • 0 views
  • 25 Jan, 2021
  • 1 location
None
Nab-paclitaxel Combined With Bevacizumab in the Treatment of Metastatic Neuroendocrine Carcinoma

This is an open-label, phase II study evaluating efficacy and safety of Nab-paclitaxel Combined With Bevacizumab for unresectable Recurrent or metastatic neuroendocrine carcinoma.

  • 0 views
  • 31 Jan, 2021
  • 1 location
None
Evaluate the Safety and Efficacy of Toripalimab Combined With Bevacizumab Versus Sorafenib Therapy for HCC

Toripalimab (hereafter referred to as JS001) combined with Bevacizumab versus Sorafenib as the first-line therapy for advanced HCC This study will enroll the patients with locally advanced or metastatic

  • 0 views
  • 03 Feb, 2021
  • 1 location